New Test Measures Coronavirus Antibodies That Can Block Future Infections

Minnesota based Imanis Life Sciences announced on September 14, 2020, an upcoming presentation about the development and validation of IMMUNO-COV™, the first scalable, quantitative neutralizing antibody test for COVID-19. In contrast to other antibody tests, the IMMUNO-COV assay specifically measures antibodies in the blood that can block infection by the SARS-Co-V-2 coronavirus that causes COVID19.